Genmab — Maj 2020
-
Fate Therapeutics plans to initiate clinical investigation of FT538 in combination with daratumumab, for the treatment of multiple myeloma. https://www.globenewswire.com/fr/news-release/2020/05/20/2036323/0/en/Fate-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-FT538-First-CRISPR-edited-iPSC-derived-Cell-Therapy.html https://fatetherapeutics.com/pipeline/immuno-oncology-candidates/ft538/
-
Jeg kan se at algoen er sat på igen i dag.
-
Zacks Investment Research: Stock Research, Analysis, & Recommendations
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Gain free stock research access to stock picks, stock screeners, stock reports, portfolio trackers and more.
Zacks Investment Research (www.zacks.com)
-
ja, tilsyneladende - men på et lidt højere niveau
-
2028...Dagens højeste. Det kan hurtigt blive en spændende mandag.
-
Proinvestor har heldigvis åben døgnet rundt.
-
Det prøvede jeg med Sparnord forleden. Det er ikke sjovt.
-
Der var da ikke problemer i formiddags?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind